Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (Tinosorb M)

A BASF-developed hybrid organic-particulate UV filter — uniquely among cosmetic actives, it operates through three concurrent mechanisms: photochemical absorption (the benzotriazolyl chromophore absorbs broad-spectrum UVA and UVB), Mie scattering (the micronised particle size reflects and refracts UV photons like a mineral filter), and reflection from the particle surface. Photostable, broad-spectrum (290–400 nm with strong UVA1 coverage), and stabilises co-formulated less-photostable filters (notably avobenzone). Particulate format means partial-scatter mechanism — clean-purist positioning depends on whether one classifies it as 'physical' or 'chemical', a definitional question rather than a chemistry question.

2–10% (commonly co-formulated with Tinosorb S and avobenzone in EU formulations)

Effective at 2–10%; commonly used with Tinosorb S, ethylhexyl triazone, and avobenzone in EU/Asia formulations. Compatible with mineral filters for hybrid systems.

Not FDA-approved (US). Particulate so technically a 'physical-chemical hybrid' — clean-puritan camp's positioning depends on definition.

FDA non-approval (US OTC monograph backlog) is the central commercial controversy — Tinosorb M has 20+ years of EU and Asian safety data the FDA has not formally evaluated, and its absence from US sunscreens is a measurable gap in available broad-spectrum cast-free options. EU classification of Tinosorb M as 'non-nano' per the regulatory definition is contested by clean-puritan campaigns despite the formal regulatory standing.

A category-defining filter in EU/Asian dermatology-led SPF (La Roche-Posay Anthelios, Avène, Bioderma) — and the absence of an equivalent in the US monograph is the persistent gap between US and global sun protection. Honest position: the underlying photochemistry and safety profile is excellent; the regulatory geography is the open question.